BELVIQ XR

Serial Number 86693918
Registration 4908131
710

Registration Progress

Application Filed
Jul 15, 2015
Under Examination
Approved for Publication
Dec 15, 2015
Published for Opposition
Dec 15, 2015
Registered
Mar 1, 2016

Attorney Assistance

Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-03-01)
Due: Mar 01, 2026 224 days

Trademark Image

BELVIQ XR

Basic Information

Serial Number
86693918
Registration Number
4908131
Filing Date
July 15, 2015
Registration Date
March 1, 2016
Published for Opposition
December 15, 2015
Cancellation Date
September 16, 2022
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Sep 16, 2022

Rights Holder

EISAI INC.

11
Address
100 TICE BLVD.
WOODCLIFF LAKE, NJ 07677

Ownership History

Arena Pharmaceuticals GmbH

Original Applicant
99
CH-4800 Zofingen CH

Arena Pharmaceuticals GmbH

Owner at Publication
99
CH-4800 Zofingen CH

Arena Pharmaceuticals GmbH

Original Registrant
99
CH-4800 Zofingen CH

EISAI INC.

New Owner After Registration #1
11
WOODCLIFF LAKE, NJ

Legal Representation

Attorney
Allison Strickland Ricketts

USPTO Deadlines

Next Deadline
224 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-03-01)
Due Date
March 01, 2026
Grace Period Ends
September 01, 2026

Application History

25 events
Date Code Type Description Documents
Sep 16, 2022 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Mar 1, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Aug 9, 2017 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 7, 2017 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 7, 2017 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 5, 2017 CORV 1 REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED Loading...
Jan 31, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 1, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 15, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 15, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 25, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 9, 2015 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 9, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 4, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 4, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 28, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 14, 2015 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Oct 14, 2015 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Oct 14, 2015 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Oct 14, 2015 ALIE A ASSIGNED TO LIE Loading...
Oct 14, 2015 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Loading...
Oct 6, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 22, 2015 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jul 21, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 18, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Additional Information

Design Mark
The mark consists of the terms "BELVIQ XR" to the right of a diamond design, intersected by a C-shaped curve design and an S-shaped curve design. The letter "X" in the term "XR" has four parallelograms stacked above one another under its bottom left side. The four parallelograms fade in color from the first one to the last one. The word "BELVIQ" and the S-shaped curve design are in red, the diamond design is in blue, and the C-shaped curve design is in white. The term "XR" and the four parallelograms under the "X" are in blue. The white areas in the mark unless identified already are not claimed as a feature of the mark, and are intended to show background or transparent areas only.
Color Claim
The color(s) blue, white, and red is/are claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"XR"